NFIB and adrenal cortex carcinoma: This review aimed to explore the molecular landscape of ACC pathogenesis, paying particular emphasis to MYB/NFIB gene fusion and its potential as a diagnostic biomarker, as well as reporting on the role of aberrant Notch signalling as prognostic markers, mutated DNA damage repair genes and epigenetic modifications as drivers of disease pathogenesis.